The following table details the insider trading activities
(stock purchases, stock sales, and stock option exercises) by Ray Debanjan since 2017.
The trader's CIK number is 1706863.
At the time of the last reporting, Ray Debanjan was the Chief Financial Officer of Cytomx Therapeutics, Inc.. (stock ticker symbol CTMX).
Also see all insider trading activities at Cytomx Therapeutics, Inc..
| Insider Buying | Insider Sales | Option Exercises | |||||
|---|---|---|---|---|---|---|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
| 2018 | CTMX | 0 | $0 | 62,048 | $1,668,021 | 57,000 | $72,543 |
| 2017 | CTMX | 0 | $0 | 15,000 | $265,799 | 0 | $0 |
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2018-12-12 | CTMX | Option Ex | 3,000 | 1.45 | 4,347 |
| 2018-12-12 | CTMX | Sale | 3,000 | 15.00 | 45,000 |
| 2018-10-01 | CTMX | Option Ex | 3,000 | 1.45 | 4,347 |
| 2018-10-01 | CTMX | Sale | 3,000 | 18.46 | 55,380 |
| 2018-09-04 | CTMX | Option Ex | 3,000 | 1.45 | 4,347 |
| 2018-09-04 | CTMX | Sale | 3,000 | 22.39 | 67,170 |
| 2018-08-01 | CTMX | Sale | 3,000 | 26.05 | 78,150 |
| 2018-08-01 | CTMX | Option Ex | 3,000 | 1.35 | 4,062 |
| 2018-07-02 | CTMX | Option Ex | 3,000 | 1.26 | 3,780 |
| 2018-07-02 | CTMX | Sale | 3,000 | 22.56 | 67,680 |
| 2018-06-01 | CTMX | Sale | 3,000 | 25.93 | 77,793 |
| 2018-06-01 | CTMX | Option Ex | 3,000 | 1.26 | 3,780 |
| 2018-05-01 | CTMX | Option Ex | 3,000 | 1.26 | 3,780 |
| 2018-05-01 | CTMX | Sale | 3,000 | 26.52 | 79,563 |
| 2018-04-02 | CTMX | Option Ex | 3,000 | 1.26 | 3,780 |
| 2018-04-02 | CTMX | Sale | 3,000 | 28.12 | 84,360 |
| 2018-03-01 | CTMX | Option Ex | 13,000 | 1.26 | 16,380 |
| 2018-03-02 | CTMX | Option Ex | 20,000 | 1.20 | 23,940 |
| 2018-03-01 | CTMX | Sale | 13,000 | 29.40 | 382,239 |
| 2018-03-02 | CTMX | Sale | 20,000 | 30.50 | 609,900 |
| 2018-02-01 | CTMX | Sale | 2,548 | 26.69 | 68,011 |
| 2018-01-02 | CTMX | Sale | 2,500 | 21.11 | 52,775 |
| 2017-12-01 | CTMX | Sale | 2,500 | 20.58 | 51,449 |
| 2017-11-01 | CTMX | Sale | 2,500 | 20.00 | 50,000 |
| 2017-10-02 | CTMX | Sale | 2,500 | 18.10 | 45,250 |
| 2017-09-01 | CTMX | Sale | 2,500 | 17.17 | 42,925 |
| 2017-08-09 | CTMX | Sale | 2,500 | 15.00 | 37,500 |
| 2017-07-03 | CTMX | Sale | 2,500 | 15.47 | 38,675 |
Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Ray Debanjan (Chief Financial Officer of Cytomx Therapeutics, Inc. at the time of this reporting) see the Securities and Exchange Commission (SEC) website.